HAEMONETICS CORP — Director's Dealing 2015

Oct 27, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2015-10-23

Reporting Person: Davies Kent J (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-10-23	Common Stock	S	278	$31.7495	Disposed	16891	Direct

Footnotes

F1: Sale required by Haemonetics policy for tax withholding purposes.